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CHARACTERIZATION OF THE MACULAR CHORIOCAPILLARIS IN DRY AGERELATED MACULAR DEGENERATION USING SWEPT-SOURCE OPTICAL
COHERENCE TOMOGRAPHY ANGIOGRAPHY
Phillip X. Braun, Nihaal Mehta, Isaac Gendelman, A. Yasin Alibhai, Eric M. Moult, Yi
Zhao, Akihiro Ishibazawa, Osama Sorour, Luisa S. M. Mendonca, Eleni K.
Konstantinou, Caroline R. Baumal, Andre J. Witkin, James G. Fujimoto, Jay S. Duker,
and Nadia K. Waheed, Department of Ophthalmology, New England Eye Center, Boston,
MA (Sponsored by Lucian Del Priore, Department of Ophthalmology and Visual
Science, Yale University School of Medicine, New Haven, CT)
The purpose of this study was to characterize further, using swept-source (SS-)
optical coherence tomography angiography (OCTA), the relationship between dry agerelated macular degeneration (AMD) and the macular choriocapillaris (CC), which may
have pathophysiologic and therapeutic implications. It included (1) a topographic
analysis to determine if there is a significant relationship between dry AMD stage and
macular CC perfusion, and (2) an investigation of the predictive value of macular CC
perfusion with respect to geographic atrophy (GA) growth rate.
Study design was retrospective and cross-sectional. A database of 6x6 mm foveacentered swept-source OCTA images of the CC from eyes with early, intermediate, and
advanced dry AMD (56 eyes, 41 patients) was generated using automated and manual
segmentation. In (1), these images were analyzed using algorithms described in the
literature to assess CC perfusion deficit metrics (flow deficit percentage (FD%) and
average flow deficit size). Regions were defined by concentric areas centered on the
fovea: a 1 mm diameter area, 3 mm diameter ring, 5 mm diameter area, 5 mm diameter
ring, and 6x6 mm whole image. Data were modeled using the generalized estimating
equations (GEE) approach. In (2), OCTA images from the database having GA as well
as corresponding autofluorescence (AF) structural imaging at multiple time points (13
eyes, 10 patients) were analyzed for CC perfusion deficit metrics. These were plotted

against the square root transformation of average GA growth rate, determined by AF over
periods up to 52 months.
Results of (1) showed that the relationship between age and CC FD% and average
flow deficit size was statistically significant (p ≤ .05) in all regions of analysis. The
relationship between dry AMD stage and FD% was statistically significant in the 5 mm
ring, and between dry AMD stage and average flow deficit size in the 3 mm ring, 5 mm
area, 5 mm ring, and 6x6 mm whole image. Results of (2) showed a significant positive
linear correlation between CC perfusion deficit metrics (flow deficit %: Pearson’s r = .68;
average flow deficit size: Pearson’s r = .69) and the square root transformation of average
GA growth rate.
In conclusion, generation of a unique database of SS-OCTA imaging of the CC in
all stages of dry AMD enabled an improved understanding of the relationship between
CC perfusion and dry AMD. Specifically, this study found a statistically significant
relationship between dry AMD stage and CC perfusion, most prominent in the more
peripheral regions of the macula, and suggested that a positive linear correlation between
CC perfusion deficit and the square root transformation of average GA growth rate holds
over periods up to 52 months.
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Introduction
Age-related macular degeneration (AMD) is a leading cause of permanent visual
loss worldwide.1 A major breakthrough in addressing this disease was the introduction of
anti-VEGF therapy, which enabled substantially improved vision in patients with wet
(neovascular) AMD.2 However, there are currently no proven therapeutic options for
patients with dry (non-neovascular) AMD.3 A major reason that dry AMD is attractive as
a therapeutic target is that, in its earlier stages, patient vision is generally much better
preserved than in its more advanced forms, which include geographic atrophy (GA) and
conversion to wet AMD.1,4 However, in order to develop potential interventions, the
pathophysiology of dry AMD must be better understood.1,5 Working towards this
understanding has been a matter of great interest, particularly of late.3,4,6,7
One line of inquiry with respect to the etiology of dry AMD concerns the role of
the choriocapillaris (CC).6 The CC interfaces with the retinal pigment epithelium (RPE)
and the photoreceptors through Bruch’s membrane, supplying metabolic needs and
removing metabolic wastes. In dry AMD, this association is frequently altered, as when
drusen separate RPE from Bruch’s membrane, or when there is CC loss. It is known that
the CC is impaired in both structure and perfusion in the various stages of dry AMD.1,6,811

Histological studies demonstrate impairment in CC structure in various stages of dry

AMD, but it is not clear whether CC loss precedes, follows, or develops simultaneously
with RPE loss, a determination that may have implications for causality.9,12-14 The
limitations of histological inquiry include restriction to post-mortem examination and
often small sample sizes. Digital fluorescein angiography (FA) is unsuitable for CC
investigation as it is not depth resolved and practical applications are limited to the

6
superficial retinal vascular plexus. Indocyanine green angiography, while able to
visualize CC circulation, also suffers from a lack of depth resolution and therefore cannot
distinguish CC flow from deeper choroidal flow.5,15
Optical coherence tomography (OCT) angiography (OCTA) offers a number of
unique advantages to investigation of the CC. OCTA is currently the only modality that
offers rapid, non-invasive, depth-resolved, in vivo imaging of CC perfusion,5,6,9,10,15
features which lend great promise for both research and clinical applications. Its
potential for CC investigation has been enhanced compared to previous-generation
instruments (e.g., spectral domain, SD-OCTA) through the use of longer-wavelength
light sources (swept sources, SS-OCTA) which enables superior signal penetration
through the highly scattering RPE, a particularly important feature for visualizing the CC
beneath additional attenuating structures such as drusen.5,10,16-19 Prototype ultrafast
devices enable shorter times between repeated OCT B-scans (interscan time), which
permits imaging of faster flow.15
Limitations of OCTA include a restriction to measurement of flow as opposed to
structure as well as limits on measurable speed of flow.5,10 OCTA also involves a
number of processing steps between image acquisition and final image rendering, which
can introduce error into representation of CC perfusion,5,20 from initial signal
thresholding to superficial projection artifact removal16 to algorithms for compensation
for shadowing beneath drusen. One of the most important steps is binarization, which
uses a thresholding algorithm to convert 8-bit (grayscale pixel values coded on a scale of
0-255) OCTA images to black and white (binary pixel values) images representing nonflow and flow, respectively. It is through binarization that qualitative OCTA images
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become quantifiable in terms of perfusion deficit metrics such as flow deficit % (FD%,
the % of pixels representing absence of flow in a given area) and average flow deficit
size. However, there is currently no consensus on binarization practice, and choice of
binarization method has been shown to result in significantly different perfusion deficit
metrics.21,22 Binarization of the CC presents unique challenges since, unlike more
superficial vasculature, the discontinuous appearance of the CC on en face imaging
precludes the use of vessel continuity as a physiologic reference. Furthermore,
established retinal imaging techniques, such as FA and color fundus photography, are not
available as accepted ground truths for comparison. Indeed, ground truths of any kind for
CC perfusion measurement are absent.23 Such challenges suggest that the current
capabilities of OCTA with respect to the CC should be tempered with some degree of
caution about physiologic and pathophysiologic interpretation.
There have been a number of investigations of the CC in dry AMD using OCTA.
Findings have included increased flow deficits in early and intermediate dry AMD versus
age-matched controls, with further focal deficits;6 flow deficits concentrated beneath
drusen using SS-OCTA and peri-drusen areas using both SD- and SS-OCTA;8,24 and loss
of CC beneath GA lesions and to a lesser extent in areas surrounding these lesions.15,17,25
Recent work on using the macular CC to predict GA growth rate using OCTA has also
been published.26,27
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Statement of Purpose
This study aimed to advance the current understanding of the relationship
between the macular CC and dry AMD via the generation of a unique database of SSOCTA images from eyes in all stages (early, intermediate, advanced) of dry AMD. Part
(1) of the study undertook a topographic analysis of the macular CC in all stages of dry
AMD to determine (A) whether dry AMD stage has a relationship with macular CC
perfusion, and (B) how this relationship (if any) varies by region. An analogous analysis
had previously occurred only in normal eyes: three groups used commercially available
SS-OCTA to characterize global perfusion characteristics of the macular CC, with all
groups finding a decrease in CC perfusion associated with advancing age that
preferentially affected the central macula.28-30 Part (2) seeks, using database images, to
extend previous work on the correlation between macular CC perfusion deficit and GA
growth rate in a more clinically useful direction. Studies using SD- and SS-OCTA have
found a statistically significant positive linear correlation between CC perfusion deficit in
6x6 mm images centered on the fovea and the square root transformation of average GA
growth rate, and a study using ultrafast prototype OCTA has qualitatively described a
similar trend.26,27,31 However, all of these perfusion deficit-growth rate studies featured
limited follow up, considering GA growth only over a maximum time period of 22
months. The current work, by contrast, considers whether the established CC perfusion
deficit-GA growth rate correlation—and thus, the potential to predict GA growth from
OCTA imaging—holds over more clinically representative durations up to 52 months.
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Methods
Generation of image database
This retrospective, cross-sectional study requiring informed consent was approved
by the Institutional Review Board of Tufts Medical Center and adhered to the
requirements of the Declaration of Helsinki and the Health Insurance Portability and
Accountability Act. All patients who had been diagnosed clinically with dry AMD in at
least one eye by a retinal specialist and were recorded in a database as having been
imaged on an SS-OCTA instrument (PLEX® Elite 9000, Carl Zeiss Meditec, Dublin, CA)
from December 2016 to September 2018 were considered for the study. Fellow eyes in
patients with a diagnosis of wet AMD were eligible for inclusion; eyes with quiescent
macular neovascularization were not. Exclusion criteria consisted of the following: poor
quality images (e.g., affected by motion artifact); retinal diagnoses or other pathologies
that could potentially affect the CC (e.g., diabetes mellitus, glaucoma), excepting
epiretinal membrane, history of retinal hole, tear, or schisis, and choroidal nevus; eyes
lacking imaging, within 9 months of their OCTA image, on an OCT instrument (Cirrus
5000 HD-OCT, Carl Zeiss Meditec, Dublin, CA) whose software was used to stage their
dry AMD; images having an OCTA signal strength of 5/10 or lower (three 6/10 images
visually inspected for quality were included, with all other images 7/10 or higher); and
myopia5,8 greater than -3.5 diopters.
Patients were subsequently staged according to the following dry AMD criteria:32
advanced eyes had GA or nascent GA as defined by lesions exhibiting increased
transmission greater than or equal to 125 μm along their greatest linear dimension on en
face OCT imaging, a size that was confirmed on OCT B-scan; intermediate eyes were
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characterized by a drusen volume greater than or equal to .02 mm3 within a 3 mm
diameter circle centered on the fovea, and did not meet criteria for advanced
classification; eyes with a drusen volume less than .02 mm3 within a 3 mm diameter
circle centered on the fovea, and which did not meet criteria for advanced classification,
were categorized as early stage.
The PLEX® Elite 9000 has an A-scan rate of 100,000 scans/second, a central
wavelength of 1060 nm, an axial resolution of ~6 μm in tissue, a lateral resolution of ~14
μm at the retinal surface, and images at a depth of 3 mm. The fovea-centered 6x6 mm en
face images used in this study, grossly encompassing the entire macula, are composed of
500 B-scans at 500 A-scans per B-scan. As in prior studies of the CC,18,26 segmentation
of the CC slab in all eyes involved maximum projection 20 μm deep to Bruch’s
membrane. For early eyes the instrument’s “RPEfit” segmentation algorithm was used,
with manual adjustment as needed; intermediate and advanced eyes were manually
segmented due to numerous drusen and RPE distortions. Additionally, regions of GA
(total RPE loss)33 in the advanced group were excluded from analysis as described in Fig.
1 to minimize detection of choroidal flow, since larger choroidal vessels tend to move
inward to occupy CC space when the CC has been lost.5,6 All manual segmentation and
exclusion of GA was performed with a precision drawing tablet (Intuos®, Wacom,
Portland, OR). Superficial vascular projections were addressed using the PLEX® Elite
software’s projection removal algorithm prior to image export.17,27 Exported images
were processed using an algorithm written in ImageJ (version 1.52h, National Institutes
of Health, Bethesda, MD) based on a previously described formula in order to
compensate for signal attenuation beneath drusen.17,18,30 Because of this compensation
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algorithm, only regions of complete signal loss on both the angiography en face image
and its structural correlate were excluded from analysis, as were any areas of significant
structural artifact.5 Images were subsequently binarized using a Phansalkar local
threshold (radius: 15 px)27,29 and inverted to highlight perfusion deficits.

Figure 1. Exclusion of GA lesions in advanced patients. PLEX® Elite “Whole Eye” structural images
were scaled appropriately then, after validation of complete RPE loss on OCT B-scan, used to create masks
which were applied to their angiographic correlates at the level of the choriocapillaris. These regions were
then excluded from concentric circular and whole image analysis for perfusion deficit metrics.

Topographic analysis
The ImageJ “Analyze Particles” command (size: 1-Infinity; circularity 0-1) was
run on five different regions of analysis for each binarized and inverted database image,
as described in Fig. 2. Perfusion deficit metrics included FD% and average flow deficit
size. In advanced eyes, regions of analysis with GA exclusions resulting in total
perfusion deficit areas of 500 px2 or less were excluded. This is approximately
equivalent to the size of a single large druse in 6x6 mm images or .05% of total 6x6 mm
area. This was done to minimize weighting perfusion deficit metrics in miniscule areas
equally with much larger (often at least an order of magnitude) corresponding regions of
analysis in other images.
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A

B

C

Figure 2. (A) OCTA image of eye with early dry AMD at the level of the superficial capillary plexus. (B)
Original OCTA image at the level of the choriocapillaris. (C) Image after signal attenuation compensation,
binarization, and inversion to show deficits rather than flow in white, overlaid with circular regions of
analysis within which particle analysis was conducted. Regions of analysis: a 1 mm diameter area centered
on the fovea, a 3 mm diameter ring (exclusive of 1 mm diameter central area), a 5 mm diameter area
centered on the fovea, a 5 mm diameter ring (exclusive of 3 mm diameter central area), and whole 6x6 mm
image.

Statistically, the object was to discern what, if any, relationship dry AMD stage
had to each of the two perfusion deficit metrics in each of the regions of analysis. In
order to discern the independent contributions by age, stage, and eye side (OD or OS) to
FD% and average flow deficit size, the generalized estimating equations (GEE) method
was used. GEE was originally designed for analysis of correlated data in repeated
longitudinal measurements, accomplishing this by estimating changes in a population
mean associated with a change in covariates using a marginal model.34 This approach to
linear modeling has also been applied to ophthalmology studies as it can account for the
correlation between fellow eyes, and has the additional advantage of not requiring
distributional assumptions.34,35 All dry AMD stages were included in a single linear
model for each perfusion deficit metric at each region of analysis (10 models total), with
each model incorporating age and eye side as covariates. A p-value of .05 was used to
determine statistical significance. Statistical analysis was performed using JMP® Pro
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(Version 13.2.1, SAS Institute Inc., Cary, NC) and R (R Foundation for Statistical
Computing, Vienna, Austria).

Choriocapillaris nonperfusion and GA growth rate
Of all database images, only those demonstrating GA as previously defined,33
clinically determined to be secondary to AMD, were used for determination of any
correlation between choriocapillaris nonperfusion and GA growth rate. The ImageJ
“Analyze Particles” command (size 1-Infinity; circularity 0-1) was performed on the
binarized and inverted whole 6x6 mm image area, which provided the perfusion deficit
metrics FD% and average flow deficit size.
Autofluorescence (AF) images taken on the Heidelberg SPECTRALIS® imaging
platform (Heidelberg Engineering, Franklin, MA) corresponding to the eyes that had
been analyzed for CC perfusion deficits were then obtained. Because this study was
retrospective and the SS-OCTA instrument used relatively new, in most cases the eyes
analyzed for CC perfusion deficit metrics had imaging only at a single point in time; thus,
there was no synchronization between OCTA and AF images. For those eyes that had
AF imaging with at least two time points, the earliest and latest available AF images
exhibiting GA were used for measuring average GA growth rate. For each AF image, the
software accompanying the SPECTRALIS®, Heidelberg Eye Explorer (version 1.10.3.0,
Heidelberg Engineering, Franklin, MA), was used to calculate manually traced GA area.
The square root transformation of this area was calculated in order to account for the
effect of baseline GA size on growth rate.36 For each eye the square root transformation
of average growth rate was thus defined as:
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√

−√

where a2 equals GA area of latest available AF image, a1 equals GA area of earliest
available image exhibiting GA, and t equals time in years.
Using JMP® Pro, for each eye CC FD% and average flow deficit size was plotted
against the square root transformation of average growth rate, and Pearson’s r was used
to assess linear correlation among all plotted points. A p-value of .05 was used to
determine statistical significance.
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Results
Generation of image database
56 eyes from 41 patients were included in the database. Staging resulted in 23
early, 12 intermediate, and 21 advanced eyes. (Detailed characteristics in Table 1.)

Patients

Eyes

Age

Sex

Age

Sex

Side

Stage

mean (SD) [range]

M

F

mean (SD) [range]

M

F

OD

OS

Early

73 (6.1) [60-85]

4

12

72 (6.3) [60-85]

5

18

14

9

Intermediate

80 (8.9) [63-88]

4

4

77 (9.9) [63-88]

7

5

5

7

Advanced

81 (7.2) [69-97]

5

12

81 (7.4) [69-97]

8

13

7

14

All patients
78 (8.0) [60-97]
13
28
77 (8.6) [60-97]
Table 1. Study patient and eye characteristics stratified by dry AMD stage.

20

36

26

30

Topographic analysis
All eyes in the image database were used in topographic analysis. Before
application of the 500 px2 total perfusion deficit area threshold to advanced eyes, because
of GA entirely consuming regions in some images there were 18, 20, 21, 21, and 21 6x6
mm images available for the 1 mm area, 3 mm ring, 5 mm area, 5 mm ring, and whole
image regions of analysis, respectively. After applying this 500 px2 threshold there were
16, 19, 21, 21, and 21 6x6 mm images available for the 1 mm area, 3 mm ring, 5 mm
area, 5 mm ring, and whole image regions of analysis, respectively.
Summary statistics for each dry AMD stage and each region of analysis are
shown in Table 2, with example images of perfusion deficits at each stage and region
shown in Fig. 3.
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Early

Flow Deficit %
Intermediate Advanced

Average Flow Deficit Size (μm2)
Early
Intermediate
Advanced

1 mm
area

mean
26.9
(SD)
(3.2)
[range] [22.0-35.5]

31.7
(7.4)
[23.9-45.0]

33.9
710.7
944.1
1349.2
(8.0)
(230.0)
(593.9)
(834.3)
[20.0-46.6] [381.1-1407.6] [418.9-2053.1] [326.2-3457.2]

3 mm
ring

mean
26.4
(SD)
(3.2)
[range] [22.1-32.7]

29.8
(5.7)
[22.5-38.6]

36.6
700.4
796.5
1479.7
(11.6)
(219.7)
(394.8)
(1023.1)
[18.7-58.1] [370.8-1119.2] [377.7-1606.7] [315.9-3701.0]

5 mm
area

mean
25.6
(SD)
(2.8)
[range] [20.7-31.8]

27.3
(4.4)
[20.8-34.2]

32.1
676.3
672.9
1239.4
(7.4)
(192.3)
(291.8)
(748.4)
[18.4-43.4] [384.5-1054.0] [353.6-1263.4] [309.0-2763.7]

5 mm
ring

25.3
mean
(2.9)
(SD)
[range] [19.7-31.3]

25.8
(3.8)
[19.6-32.1]

31.4
655.7
587.1
1157.0
(7.4)
(192.3)
(240.3)
(676.3)
[18.2-43.0] [381.1-1005.9] [329.6-1060.9] [298.7-2396.4]

Whole
image

mean
25.2
(SD)
(2.9)
[range] [19.5-31.9]

25.9
(3.8)
[19.5-31.8]

30.1
669.5
604.2
1050.6
(6.4)
(192.3)
(247.2)
(535.6)
[18.6-39.2] [394.8-1084.9] [336.5-1091.8] [315.9-2087.4]

Table 2. Summary statistics for all dry AMD stages and regions of analysis. Abbreviation: SD is standard
deviation.

A

B

C

Figure 3. Binarized and inverted images (choriocapillaris perfusion deficits in white) of eyes with early
(A), intermediate (B), and advanced (C) dry AMD, overlaid with regions of analysis. The blue outline in C
represents areas of geographic atrophy, which were excluded from analysis.

On GEE analysis (Table 3), the relationship between age and both perfusion
deficit metrics was significant in all regions of analysis. Peripheral regions most
consistently demonstrated a significant relationship between stage and both perfusion
deficit metrics: FD% p ≤ .05 in the 5 mm ring region of analysis, and average flow deficit
size p ≤ .05 in the 3 mm ring, 5 mm area, 5 mm ring, and whole image regions of
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analysis. There was no significant relationship between eye side and perfusion deficit
metrics in any region of analysis.1

Age

Flow Deficit %

Average Size

1 mm area

1 mm area

Side

Inter-stage comparison

.008†

.854

early vs. intermediate
early vs. advanced
intermediate vs. advanced

Age

Side

Inter-stage comparison

.825

early vs. intermediate
early vs. advanced
intermediate vs. advanced

Stage
.140
.170
.903

Age

Side

Inter-stage comparison

.005†

.537

early vs. intermediate
early vs. advanced
intermediate vs. advanced

Age

Side

Inter-stage comparison

.060

early vs. intermediate
early vs. advanced
intermediate vs. advanced

3 mm ring

.002†

3 mm ring
Stage
.484
.054
.115

.005†

5 mm area
Age
1E-5‡

Side

Inter-stage comparison

.951

early vs. intermediate
early vs. advanced
intermediate vs. advanced

Side

Inter-stage comparison

2E-5‡

.976

early vs. intermediate
early vs. advanced
intermediate vs. advanced

Age

Side

Inter-stage comparison

.433

early vs. intermediate
early vs. advanced
intermediate vs. advanced

Stage
.661
.120
.064

Age
3E-4‡

Side

Inter-stage comparison

.266

early vs. intermediate
early vs. advanced
intermediate vs. advanced

Stage
.060
.110
.007†

5 mm ring
Stage
.177
.170
.016*

Age

Side

Inter-stage comparison

8E-5‡

.438

early vs. intermediate
early vs. advanced
intermediate vs. advanced

Age

Side

Inter-stage comparison

.805

early vs. intermediate
early vs. advanced
intermediate vs. advanced

Whole image

3E-7‡

Stage
.283
.102
.036*

5 mm area

5 mm ring
Age

Stage
.722
.162
.365

Stage
.015*
.135
.002†

Whole image
Stage
.248
.280
.056

3E-5‡

Stage
.013*
.231
.005†

Table 3. P-values of model terms (linear regression coefficients for age, eye side, stage) for all regions of
analysis. Boldface indicates statistical significance defined as p ≤ .05; * ≤ .05, † ≤ .01, ‡ ≤ .001.
Abbreviation: side is eye side (OD vs. OS comparison), average size is average flow deficit size.

1

While this study assessed the significance of model regression coefficients, it did not explore the models
in depth or use them for flow deficit prediction. For a brief exploration of this subject, cf. Appendix.
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Choriocapillaris nonperfusion and GA growth rate
The database contained images of 18 eyes with GA. From this set of 18 eyes, 13
eyes from 10 subjects (Table 4) also had AF imaging exhibiting GA at two time points or
more. Table 5 presents a summary of data used in correlation determinations. Mean
duration between baseline AF image and final AF image was 36.6 months (standard
deviation 14.3, range 15-52).

Patients
Age
Sex
mean (SD) [range] M
F
79 (6.0) [70-88]
4
6

Eyes
Age
Sex
mean (SD) [range]
M
F
79 (6.3) [70-88]
7
6

Side
OD OS
6
7

Table 4: Detailed characteristics for study patients and eyes. Abbreviation: SD is standard deviation.

Time
Square root
between
GA
GA
CC
transformation of
baseline initial
final
average
Patient Laterality Focality
average GA
CC FD%
AF and
area
area
flow deficit
growth rate
2
2
final AF (mm ) (mm )
size (µm2)
(mm/year)
(months)
43.55
1264.49
OS
Uni
7.40 12.92
1
47
0.225
OS
Uni
2.40
2.69
20.42
838.05
2
32
0.015
OD
Multi
.57
1.91
15.58
887.90
3
43
0.175
OD
Uni
21.28
28.87
13.90
864.76
4
49
0.186
OS
Uni
25.05 35.41
13.05
805.44
4
49
0.232
OS
Uni
.26
.80
9.15
637.28
5
48
0.096
OS
Uni
.87
1.03
16.20
920.14
6
15
0.066
OD
Multi
.13
.26
14.23
846.94
7
37
0.048
OD
Uni
12.72 17.72
23.14
893.29
8
39
0.243
OS
Multi
15.64 22.41
26.23
955.19
8
39
0.261
41.20
1206.23
OD
Uni
14.97
17.76
9
13
0.319
OS
Uni
8.57 10.95
35.20
1144.95
9
13
0.352
OD
Uni
5.74
13.27
56.28
1345.10
10
52
0.303
Table 5: Data used for correlation determination by patient and eye. Abbreviations: AF is
autofluorescence, GA is geographic atrophy, CC is choriocapillaris, FD% is flow deficit percentage.
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Perfusion deficit metric vs. square root transformation of average growth rate
results are shown in Fig. 4. The linear regression equations were as follows for FD% and
average flow deficit size, respectively: y = .0048x + .068 with a Pearson’s r of .68 (p =
.01 for x coefficient); y = .00034x - .14 with a Pearson’s r of .69 (p = .009 for x
coefficient). 3 patients contributed both eyes to this part of the study, introducing the
possibility of confounding fellow eye correlation; however, following Thulliez et al.,26
random removal in the data set of one of these eyes from each of these patients actually
resulted in a stronger linear correlation (r = .76 (p ≤ .05) for both FD% and average flow
deficit size).

Figure 4. Perfusion deficit metrics (flow deficit %, left; average flow deficit size, right) plotted against
square root transformation of average geographic atrophy growth rate, fitted with linear regression
trendlines.
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Discussion
Generation of image database
It is important to note the difficulties of segmentation in OCTA studies of the CC
when the RPE is distorted, as in more advanced dry AMD, since this has implications for
the accuracy of calculated perfusion deficit metrics. Visual inspection of segmentation
lines on OCT B-scans suggests the PLEX® Elite’s auto-segmentation algorithm is
currently unable to accurately identify Bruch’s membrane in these cases. More work is
required on the repeatability and reproducibility of both automated and manual
segmentation of the choriocapillaris slab.
The Phansalkar local (radius: 15 px) binarization method, based on the mean and
standard deviation of grayscale values within a given radius, was developed for effective
binarization in low-contrast settings.21 It was used in this study because of the lowcontrast character of the CC, its reported reasonable approximation of CC flow deficit
size, and its prevalence in the OCTA CC quantification literature.21,24,27,29,37 However, in
the absence of a gold standard means of quantifying CC flow,23 results from this or any
other binarization method must be interpreted with caution.

Topographic analysis
Previous OCTA studies of the CC in dry AMD have focused on individual lesions
and their surrounding areas,15,17,19,27 with some limited work on global analysis and
staging.6,8,24 This part of our study endeavored to investigate the CC quantitatively
throughout the macula in all stages of dry AMD. To address the central questions posed
by this part of our study, results (A) reaffirm the conclusion of previous studies that that
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there is a strong correlation of perfusion deficit metrics in the macular CC with age, and
(B) suggest that there is a relationship between dry AMD stage and CC flow deficits,
which is more pronounced 3-5 mm from the fovea than centrally.
Our findings are supported by prior work suggesting that GA has a propensity to
begin extrafoveally and that GA growth rate varies with topographic location, with
extrafoveal lesions demonstrating slower growth towards the fovea than towards the
periphery.38-40 Results of our study seem consistent with the findings of Seddon et al.,9
who found CC attenuation with advancing dry AMD stage, particularly from the
intermediate to the advanced (GA) stage. A histological study of macular topography has
not been performed.

Choriocapillaris nonperfusion and GA growth Rate
GA is a particularly devastating form of AMD with its complete loss of RPE and
outer retinal atrophy,33 and thus complete loss of function in the affected area. In clinical
settings it would be useful to reliably predict rate of GA growth in order to inform
patients about visual prognoses. Likewise, much effort has been devoted to developing
therapeutics to limit GA growth,41-44 and for these purposes it would be useful to be able
to stratify subjects into higher and lower tiers with respect to risk of GA expansion.
Numerous studies have shown that there is great heterogeneity in GA growth rate based,
for instance, on lesion characteristics (e.g., size, unifocality vs. multifocality, distance
from fovea)38-40,45-47 and a reliable way of predicting growth rate of a lesion, without
reliance on longitudinal imaging, had been lacking. While longitudinal imaging can
provide a reference growth rate that is one of the best predictors of future growth rate,40,48
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for any number of reasons this imaging may be unavailable for all patients with GA in
different clinical settings.
Recently, two groups potentially addressed this need for a longitudinallyindependent means of GA growth rate prediction. Thulliez et al. and Nassisi et al. were
the first to report a positive linear correlation between CC perfusion deficit and GA
growth rate using OCTA.26,27 Our study followed these studies in calculating average
GA growth rate using the square root transformation of lesion area, though it has been
demonstrated that, due to the proportionality between lesion radius and area, it is
appropriate simply to use lesion radius for GA growth rate calculation.49 Thulliez et al.
found that the perfusion deficit-growth rate correlation was stronger when areas of CC
perfusion further from GA were included, whereas Nassisi et al. observed that strength of
correlation was increased in areas more proximal to GA. In both studies, the CC
perfusion deficit immediately adjacent to GA was not strongly correlated with GA
growth rate (Thulliez et al., 300 µm-wide para-lesion band: Pearson’s r = .40, p = .06 for
FD% vs. square root transformation of average growth rate, Pearson’s r = .54, p = .009
for average flow deficit size vs. square root transformation of average growth rate;
Nassisi et al., 500 µm-wide para-lesion band: Pearson’s r = .579, p < .001 for FD% vs.
square root transformation of average growth rate). This was surprising because
histology had suggested a relationship between CC loss and GA, including in
surrounding regions,9,11-13 and because CC loss in the setting of GA had been documented
on OCTA.15,25 Such studies suggested that GA would extend more rapidly into areas of
diminished CC perfusion (i.e., around GA lesions12,13,15,17) in a predictable way. Both
Thulliez et al. and Nassisi et al. attributed the difference between their results and the
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expected results to the recent studies showing that age preferentially affects the central
macular CC,29,30 potentially confounding any effects of disease. Lesion dimensions and
focality were also identified as potential confounders.
Using the same swept-source OCTA instrument as well as the same area (full 6x6
mm image minus GA area) as our study, Thulliez et al. found when correlating CC
perfusion deficit metrics to the square root transformation of average GA growth rate a
Pearson’s r = .63 (p ≤ .05) for FD% and r = .75 (p ≤ .05) for average flow deficit size.
The mean follow-up time for the Thulliez et al. study was 12.8 months with a range of
11.1-16.1 months. They noted that their average flow deficit size had a stronger
correlation with the square root transformation of average growth rate than FD% did. We
were not able to demonstrate the same conclusion (r = .68 and .69 for FD% and average
flow deficit size, respectively), but strength of correlation for both perfusion deficit
metrics by Pearson’s r was similar. Nassisi et al. did not find a significant correlation
between 6x6 mm image (minus areas of GA) FD% and square root transformation of
average GA growth rate, but this study used shorter-wavelength spectral domain OCTA,
which has greater difficulty imaging CC flow through drusen attenuation and RPE
scattering. However, it did find a fairly strong correlation between the difference in FD%
among peri- and para-GA regions and the square root transformation of GA growth rate.
This correlation featured r = .681 (p ≤ .05), which is similar to the Pearson coefficient
found in our study for FD%, although comparison is limited by use of different OCTA
instruments and different macular areas investigated. Mean follow-up time for the
Nassisi et al. study was 15.7 months with a standard deviation of 2.4 months.
Additionally, a perfusion deficit-growth rate study using prototype, ultrafast OCTA
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qualitatively described a positive correlation between 6x6 mm image (minus areas of
GA) FD% and square root transformation of average GA growth rate.31 Measures of
correlation were not calculated due to small sample size (7 eyes). Mean follow-up time
in this study was 12.4 months with a standard deviation of 5.7 months and a range of 9 to
22 months.
In our study, the mean (36.6 months) and maximum (52 months) length of time
over which the CC perfusion deficit-growth rate correlation holds is substantially greater
than in previous studies, suggesting that this correlation holds over long periods of time.
This observation is auspicious for the potential predictive value of CC nonperfusion for
GA growth rate in clinical settings where longitudinal follow-up may occur over shorter
or longer durations, up to several years.
Furthermore, all three mentioned perfusion deficit-growth rate studies acquired
baseline structural (OCT) imaging and OCTA imaging. Our study found a similar extent
of perfusion deficit-growth rate correlation using unsynchronized images, suggesting that
a fovea-centered 6x6 mm OCTA image of CC perfusion at a single time point during the
course of GA growth may be predictive of the lesion’s growth rate. Finally, as is the case
in the Thulliez et al. and Nassisi et al. perfusion deficit-GA growth rate studies, it is
difficult for our study to comment on how the perfusion deficit-growth rate correlation
applies to different growth patterns (e.g., unifocal vs. multifocal) due to low power when
the study cohort is divided into sub-groups. However, as it is the study cohort contributes
to an understanding of the perfusion deficit-growth rate correlation. This is the fourth
study to have done so, in a manner that demonstrates good agreement with three prior
related studies. For the purpose of future clinical trials, it may be important to stratify
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growth rates based on perfusion deficit metrics (e.g., at what FD% fast-growers should be
distinguished from slow-growers).31

Conclusions
In summary, this study involved the generation of unique database of SS-OCTA
images of the macular CC in early, intermediate, and advanced dry AMD. There are
several important conclusions from this study:
(1) There was a statistically significant relationship between dry AMD stage and CC
perfusion after controlling for age and eye side. This relationship was found to be
more prominent in the macular periphery than in the central macula. This
observation is consistent with prior studies showing that GA tends to begin
outside the foveal region and with the current understanding of GA kinetics.
Further work in this area would include increasingly robust and regional
histological characterization of the macular CC, as well as more granular global
macular analysis of CC perfusion in the phenotypically heterogenous advanced
dry AMD stage.
(2) This study suggests that the positive linear correlation between CC perfusion
deficit and the square root transformation of average GA growth rate holds over a
duration as long as 52 months. Additionally, OCTA imaging at a single point in
time during GA growth may be predictive of the rate of this growth. Such
findings are important for predicting GA growth rates in clinical settings,
including clinical trials. Future work would involve longitudinal OCTA imaging,
as well as adequately powered studies on different spatial and temporal GA
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growth patterns (e.g., unifocal vs. multifocal; linear vs. sigmoidal vs.
logarithmic), which could allow further comment on the relationship among GA
growth rate, lesion characteristics, and CC perfusion.
Study weaknesses included its retrospective character, failure to account for
hypertension,37 lack of a control population (especially in Topographic analysis), and a
small sample size for eyes with intermediate dry AMD as well as for eyes with both GA
and longitudinal AF imaging. As noted in related studies,26,27 residual superficial
projection artifact may still have some effect on CC perfusion imaging despite the use of
projection removal software, which is a challenge of imaging the CC on OCTA.
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Appendix
The purpose of the Topographic analysis component of this study was to
investigate whether there was a significant relationship between dry AMD stage and
macular CC perfusion, and where in the macula any such relationship might apply.
While its scope did not include deployment of the ten models used to answer these
questions—determination of the significance of their regression coefficients was
sufficient—these models are explored briefly in this appendix, including demonstration
of their ability to predict CC perfusion in different stages of dry AMD in certain cases.
Model coefficients determined through GEE analysis are as follows for FD%
(display adapted from original output in R using “geeglm” package; * ≤ .05, ** ≤ .01,
*** ≤ .001):

1 mm area
Estimate Std.err p-value
Age

0.3610

0.1360

0.0077 **

Eye side

0.2520

1.3730

0.8546

Stage: Early (ref) vs. Intermediate

2.8120

1.9070

0.1403

Stage: Early (ref) vs. Advanced

3.1460

2.2940

0.1702

Stage: Intermediate (ref) vs. Advanced

0.3340

2.7430

0.9031

Intercept (Early ref)

0.7480

9.9890

0.9403

Intercept (Intermediate ref)

3.5600

0.1200

0.7339

3 mm ring
Estimate Std.err p-value
Age
Eye side

0.4250

0.1380

0.0021 **

-0.3980

1.7970

0.8246

Early (ref) vs. Intermediate

1.2360

1.7660

0.4839

Early (ref) vs. Advanced

5.6980

2.9620

0.0544

Intermediate (ref) vs. Advanced

4.4620

2.4800

0.1155

Intercept (Early ref)

-4.0390

0.1600

0.6853

Intercept (Intermediate ref)

-2.8030

10.8190

0.7956
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5 mm area
Estimate Std.err p-value
Age
Eye side
Stage: Early (ref.) vs. Intermediate
Stage: Early (ref.) vs. Advanced
Stage: Intermediate (ref.) vs. Advanced

0.3946

0.0894

1e-05 ***

0.0516

0.8451

0.9510

-0.5937

1.3543

0.6600

2.7533

2.4700

0.1200

3.3470

1.8046

0.0640

Intercept (Early ref)

-2.8247

6.5058

0.6600

Intercept (Intermediate ref)

-3.4184

7.1523

0.6330

5 mm ring
Estimate Std.err p-value
Age

0.3870

0.0804

1.5e-06 ***

Eye side

-0.0267

0.8978

0.9760

Stage: Early (ref.) vs. Intermediate

-1.7463

1.2931

0.1800

2.4752

1.7840

0.1700

Stage: Early (ref.) vs. Advanced
Stage: Intermediate (ref.) vs. Advanced

4.2215

1.7540

0.0160 *

Intercept (Early ref)

-2.5627

5.8303

0.6600

Intercept (Intermediate ref)

-4.3091

6.3989

0.5010

Whole 6x6 mm image
Estimate Std.err p-value
Age

0.3730

0.0730

3.2e-07 ***

Eye side

-0.5760

0.7360

0.4300

Stage: Early (ref.) vs. Intermediate

-1.3040

1.1280

0.2500

1.5790

1.1600

0.2800

Stage: Early (ref.) vs. Advanced
Stage: Intermediate (ref.) vs. Advanced

2.8830

1.5100

0.0560

Intercept (Early ref)

-1.4620

5.2990

0.7800

Intercept (Intermediate ref)

-2.7660

0.2300

0.6310

The only model that shows a significant correlation of stage with CC FD% is the 5 mm
ring. This model is plotted in Supplementary Fig. 1.
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Supplementary Figure 1. Plot of model for 5 mm ring FD% with dry AMD stage and age as significant
covariates. Equation for intermediate stage: FD% = .387(age). Equation for advanced stage: FD% =
.387(age) + 4.222

Model coefficients determined through GEE analysis are as follows for average
flow deficit size:

1 mm area
Estimate Std.err p-value
Age

0.9400

0.3340

0.0049 **

Eye side

2.2550

3.6530

0.5370

Stage: Early (ref) vs. Intermediate

1.3870

3.8960

0.7219

Stage: Early (ref) vs. Advanced

7.6140

5.4470

0.1622

Stage: Intermediate (ref) vs. Advanced

6.2280

6.8810

0.3654

Intercept (Early ref)

-47.9490

24.7840

0.0530

Intercept (Intermediate ref)

-46.5630

25.2160

0.0648

3 mm ring
Estimate Std.err p-value
Age
Eye side
Stage: Early (ref) vs. Intermediate
Stage: Early (ref) vs. Advanced
Stage: Intermediate (ref) vs. Advanced

1.0500

0.3710

0.0047 **

4.5290
-4.4630
8.9020

2.4070
4.1590
5.4450

0.0599
0.2833
0.1021

13.3650

6.3610

0.0356 *

Intercept (Early ref)

-57.1520

27.7540

0.0395 *

Intercept (Intermediate ref)

-61.6150

30.1850

0.0412 *
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5 mm area
Estimate Std.err p-value
Age
Eye side
Stage: Early (ref) vs. Intermediate

0.9230
2.3180
-6.1070

0.2540
2.0830
3.2520

2.8e-4
0.2658
0.0604

7.1950

4.5080

0.1105

13.3010

4.8930

0.0066

Intercept (Early ref)

-47.8980

18.9970

0.0117

*

Intercept (Early ref)

-54.0040

20.5360

0.0086

**

Stage: Early (ref) vs. Advanced
Stage: Intermediate (ref) vs. Advanced

***

**

5 mm ring
Estimate Std.err p-value
Age
Eye side
Stage: Early (ref) vs. Intermediate
Stage: Early (ref) vs. Advanced

0.8290
1.7490
-7.1540

0.2100
2.2570
2.9490

7.8e-05 ***
0.4383
0.0153 *

6.4790

4.3350

0.1350

13.6330

4.4760

0.0023 **

Intercept (Early ref)

-41.4930

15.7130

0.0083 **

Intercept (Intermediate ref)

-48.6470

16.9260

0.0041 **

Stage: Intermediate (ref) vs. Advanced

Whole 6x6 mm image
Estimate Std.err p-value
Age
Eye side
Stage: Early (ref) vs. Intermediate
Stage: Early (ref) vs. Advanced
Stage: Intermediate (ref) vs. Advanced

0.7360
0.4050
-6.2400

0.1750
1.6350
2.5220

2.7e-05 ***
0.8046
0.0133 *

4.1940

3.5010

0.2309

10.4340

3.7270

0.0051 **

Intercept (Early ref)

-33.8020

13.0530

0.0096 **

Intercept (Intermediate ref)

-40.0430

13.8050

0.0037 **

Models that show a significant correlation of stage with CC FD% include the 3 mm ring,
5 mm area, 5 mm ring, and 6x6 mm whole image. These models are plotted in
Supplementary Figs. 2-5.
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Supplementary Figure 2. Plot of model for 3 mm ring average flow deficit size with dry AMD stage and
age as significant covariates, including a significant intercept value. Equation for intermediate stage:
average flow deficit size = 34.332(1.05(age) – 61.615). Equation for advanced stage: average flow deficit
size = 34.332(1.05(age) – 48.250). 34.332 is a constant to convert px2 to um2.

Supplementary Figure 3. Plot of model for 5 mm area average flow deficit size with dry AMD stage and
age as significant covariates, including a significant intercept value. Equation for intermediate stage:
average flow deficit size = 34.332(.923(age) – 54.004). Equation for advanced stage: average flow deficit
size = 34.332(.923(age) – 40.703). 34.332 is a constant to convert px2 to um2.
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Supplementary Figure 4. Plot of model for 5 mm ring average flow deficit size with dry AMD stage and
age as significant covariates, including a significant intercept value. Equation for early stage: average flow
deficit size = 34.332(.829(age) – 41.493). Equation for intermediate stage: average flow deficit size =
34.332(.829(age) – 48.647). Equation for advanced stage: average flow deficit size = 34.332(.829(age) –
35.014). 34.332 is a constant to convert px2 to um2.

Supplementary Figure 5. Plot of model for whole 6x6 mm image average flow deficit size with dry AMD
stage and age as significant covariates, including a significant intercept value. Equation for early stage:
average flow deficit size = 34.332(.736(age) – 33.803). Equation for intermediate stage: average flow
deficit size = 34.332(.736(age) – 40.043). Equation for advanced stage: average flow deficit size =
34.332(.736(age) – 29.609). 34.332 is a constant to convert px2 to um2.
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One surprising finding among the plotted models is the increased flow deficit size
of the early stage relative to the intermediate stage in the 5 mm ring and whole 6x6 mm
image. However, the study’s use of two different perfusion deficit metrics that should be
positively correlated may give some reason to be less confident about the early stage
models and more confident about the intermediate and advanced stage models.
Anatomically, when FD% increases, assumedly due to real or effective CC vessel loss,
the space between areas of flow (average flow deficit size) should enlarge. The 5 mm
area, 5 mm ring, and whole 6x6 mm image involve either significant or very nearly
significant stage (intermediate vs. advanced) coefficients that show an increase in FD%
with advancing stage, and the significant stage (intermediate vs. advanced) coefficients
for average flow deficit size in these regions corroborate this increased perfusion deficit
with advancing stage. Agreement between FD% models and average flow deficit size
models is less consistent with respect to the significance or near-significance of
coefficients involving the early stage.
Supplementary Table 1 contains a summary of all equations derived from this
study that were used to predict CC perfusion deficit metrics based on dry AMD stage.
Supplementary Fig. 6 shows, topographically, selected conclusions from deployment of
study models for perfusion deficit metric prediction.
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Flow Deficit %

Average Size

1 mm area

1 mm area

No models with significant stage terms

No models with significant stage terms

3 mm ring

3 mm ring

No models with significant stage terms

Intermediate: y = 36.049(age) – 2115.4
Advanced: y = 36.049(age) – 1656.5

5 mm area

5 mm area

No models with significant stage terms

Intermediate: y = 31.688(age) – 1854.1
Advanced: y = 31.688(age) – 1398.3

5 mm ring

5 mm ring

Intermediate: y = .387(age)
Advanced: y = .387(age) + 4.222

Early: y = 28.461(age) – 1424.5
Intermediate: y = 28.461(age) – 1670.1
Advanced: y = 28.461(age) – 1202.1

Whole image

Whole image

No models with significant stage terms

Early: y = 25.268(age) – 1160.5
Intermediate: y = 25.268(age) – 1374.8
Advanced: y = 25.268(age) – 1016.5

Supplementary Table 1. Equations derived from study’s topographic analysis that have significant stage
terms.

+ 460 μm2
+ 468 μm2
+ 4.22 %
Supplementary Figure 6. Topographic representation of perfusion deficit models in 3 mm ring (blue) and 5
mm ring (green) centered on the fovea of a binarized and inverted OCTA image. Only intermediate and
advanced models are considered in this figure. Yellow numbers indicate predicted increase in average flow
deficit size for advanced eyes vs. intermediate eyes in each region. White number indicates predicted
increase in FD% for advanced eyes vs. intermediate eyes in 5 mm ring.
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